"尼克洛萨米德:一种潜在的抗剂,通过调节通过甲基酸盐受体 (mGluRs) 调节血清素通路"
Zahra Ebrahim Soltani1, Mohammad Elahi2, Maziyar Askari Rad3
1Experimental Medicine Research Center, Tehran University Medical Science, Tehran, Iran.
Heliyon
|July 12, 2024
概括
一种现有的药物尼克洛萨米德通过准特定的大脑受体,有效地减少了小鼠的. 这表明它有可能成为一种新的治疗方法,特别是当抗组胺药物失败时.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- () 通常是由血清素触发的,激活了抗组胺药物耐药的通路.
- 血清作为炎症调解剂,有助于持续的.
- 目前的治疗方法,如抗胰岛素药物,往往不足以控制某些类型的.
研究的目的:
- 为了研究尼克洛萨米德的抗效应.
- 探索尼克洛萨米德对路径中涉及的特定受体的影响.
- 为了评估尼克洛萨米德在小鼠模型中所产生的效果,以测试这种类型的血清性.
主要方法:
- 利用小鼠模型来研究血清性.
- 施用不同剂量的尼克洛萨米德.
- 检查了元类谷氨酸受体 (mGluR1,mGluR5),5-HT2和TRPV1.1的表达水平.
主要成果:
- 尼克洛萨米德的5mg/kg剂量显著抑制了小鼠的.
- 尼克洛萨米德的使用导致mGluR1,mGluR5,5-HT2和TRPV1水平显著降低.
- 该药物在基因组胺独立的模型中显示出有效性.
结论:
- 尼克洛萨米德显示出作为潜在的治疗的治疗剂的希望.
- 药物的机制可能涉及调节mGluRs和其他与有关的途径.
- 对尼克洛萨米德的进一步研究可能会导致新的抗治疗方法.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
244
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
244
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
Sedatives and Hypnotics Drugs: Miscellaneous Agents
166
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
166
Antiepileptic Drugs: Glutamate Antagonists
316
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
316
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158


